Glucagon-like peptide-1 (GLP-1) analogs have emerged as a compelling therapeutic avenue for managing metabolic syndromes. These naturally occurring substances are secreted by the gut in response to meal intake, https://myfirstbookmark.com/story20490288/unveiling-the-therapeutic-potential-of-glp-1-peptides